Show simple item record

Authordc.contributor.authorChedraui, Peter 
Authordc.contributor.authorPérez López, Faustino R. es_CL
Authordc.contributor.authorBlumel, Juan E. es_CL
Authordc.contributor.authorHidalgo, Luis es_CL
Authordc.contributor.authorBarriga, José es_CL
Admission datedc.date.accessioned2010-07-13T19:18:03Z
Available datedc.date.available2010-07-13T19:18:03Z
Publication datedc.date.issued2009
Cita de ítemdc.identifier.citationGynecological Endocrinology, Month 2009; 00(0): 1-7en_US
Identifierdc.identifier.issn0951-3590 print
Identifierdc.identifier.otherDOI: 10.1080/09513590903184092
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/128686
Abstractdc.description.abstractBackground. Postmenopausal metabolic changes increase cardiovascular risk and impair quality of life (QoL). Despite this, few reports have addressed the association of these changes with female sexuality. Objective. To determine the association between the metabolic syndrome (METS), and its components, and female sexuality. Methods. Data of sexually active postmenopausal women who participated in a METS screening program who lled out the menopause-speci c quality of life questionnaire (MENQOL) were assessed. Speci cally the sexual domain of the MENQOL was analyzed in regard to mean total and item scores (decreased libido, vaginal dryness, and sexual avoidance). Criteria of the Third Adult Treatment Panel (ATP III) were used to identify women with the METS. Results. Two hundred six women ful lled inclusion criteria. Mean age of participants was 54+6.9 years (median: 54 years). Prevalence of the METS in this sexually active postmenopausal series was 39.8%. About 52.9% of them presented abdominal obesity, 35.4% hypertension, 55.8% high triglycerides, 17.5% hyperglycemia, and 59.7% low high density lipoprotein cholesterol (HDL-C). Women with the METS as compared with those without the syndrome displayed no signi cant differences in MENQOL sexual scorings (total or of its composing items). Equally there were also no score differences among those presenting any of the ve components of the METS, except women with hyperglycemia who signi cantly displayed a higher total sexual domain score (5.6+2.1 vs. 4.8+2.3, p50.05) in association to a higher mean score in the decreased libido item (6.0+2.3 vs. 4.8+2.6, p50.01). After controlling for several confounding factors, logistic regression con rmed that women with hyperglycemia were signi cantly at higher risk for presenting decreased libido (higher item score, OR 2.4, CI 95%: 1.0 5.7, p50.05) and more impaired sexuality (higher total MENQOL sexual domain score: OR, 2.5, CI 95%: 1.1 5.4, p50.05). Conclusion. Despite the limitations of this study, as assessed with the MENQOL, hyperglycemia in postmenopausal women screened for the METS was associated to a negative impact in sexuality. More research is warranted in this regard.en_US
Patrocinadordc.description.sponsorshipThis study was supported by the Research and Development System of the Universidad Cato´ lica de Santiago de Guayaquil, Ecuador through grant No. 2003-10-83 and partially supported by the B/ 017543/08 AECID (Agencia Espan ola de Cooperacio´n Internacional para el Desarrollo) grant from the Spanish Ministerio de Asuntos Exteriores y Cooperacio ´n to the University of Zaragoza, Spain.en_US
Lenguagedc.language.isoenen_US
Keywordsdc.subjectMenopauseen_US
Títulodc.titleHyperglycemia in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaintsen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record